N2-Acetylaciclovir

CAS No. 110104-37-5

N2-Acetylaciclovir( —— )

Catalog No. M33707 CAS No. 110104-37-5

N2-Acetylaciclovir (Aciclovir EP Impurity F) is a derivative of the antiviral compound Aciclovir, which has selective T-cell immunotoxicity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
5MG 70 In Stock
10MG 107 In Stock
25MG 187 In Stock
50MG 274 In Stock
100MG 384 In Stock
200MG 548 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N2-Acetylaciclovir
  • Note
    Research use only, not for human use.
  • Brief Description
    N2-Acetylaciclovir (Aciclovir EP Impurity F) is a derivative of the antiviral compound Aciclovir, which has selective T-cell immunotoxicity.
  • Description
    N2-Acetylaciclovir (Aciclovir EP Impurity F) is a derivative of the antiviral compound Aciclovir, which has selective T-cell immunotoxicity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    110104-37-5
  • Formula Weight
    267.24
  • Molecular Formula
    C10H13N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OCCO)N1C2=C(C(=O)N=C(NC(C)=O)N2)N=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Garenoxacin mesylate...

    A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.

  • HMPC

    HMPC is a novel bacteriostatic agent that shows bacteriostatic activity against S. aureus (MIC=4?μg/ml) and rescues Caenorhabditis elegans from S. aureus infection.

  • Capreomycin sulfate

    A peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis.